1. Interim Prediction of Two-year All-cause Mortality in Patients with de novo Multivessel Coronary Artery Disease Undergoing Intended Multivessel PCI

M Renkens

  • In 563 patients, the median predicted 2-year all-cause mortality was 1.9%
  • Older age, impaired LVEF, and an increased anatomical SYNTAX-I score were the main contributors to high mortality
  • Accurate prediction helps in
  • Mortality risk prediction
  • 3VD patients to make informed choices
  • Utilize intravascular imaging techniques for the disease


  1. Percutaneous Coronary Intervention and Medical Therapy versus Medical Therapy Alone in Chronic Coronary Syndrome: A Hierarchical Win-ratio Analysis from SCAAR

S Von Koc

  • Revascularization with PCI did not result in better outcomes when compared to medical therapy alone
  • For patients with CCS, medical therapy may be just as effective as PCI in improving outcomes


  1. Predicting the Death Caused by Cardiovascular and/or Cerebrovascular Disease within 7 Years Follow-up Using Machine Learning Models

K Tsarapatsani

  • LightGBM was the most accurate model, achieving 87.56 %
  • Machine learning models achieved accurate prediction of cardiovascular and cerebrovascular death for 7 years of follow-up utilizing basic medical data


  1. Updating Cardiovascular Disease Risk Prediction Equations to Account for Lipid-lowering Treatment Drop-in During Follow-up: A National Data-linkage Cohort

J Liang

  • Incorporating a time-dependent lipid-lowering medication effect is an effective approach for addressing treatment drop-in in CVD risk prediction equations
  • Traditional methods to evaluate model performance are unable to identify the impact of treatment drop-in


  1. Digital health in hypertension management: utile or futile

Using Apps in Hypertension: A Way to Improve Blood Pressure

A Mihailidou

  • Apps incorporating more comprehensive functionalities will be more effective
  • The goal is Engagement
  • Partnership between patient, caregiver, and physicians to empower adherence to self-management
  • Assess health literacy and cultural sensitivities
  • Verify that it has been tested for equivalent efficacy for low and high socioeconomic status people


  1. Guideline-directed medical therapy in heart failure: novel implementation strategies

Novel Strategies in Heart Failure Management

A Rakisheva

  • Rapid up-titration of HF therapies is safe and reduces HF readmissions or all-cause deaths
  • HFpEF patients have heterogeneous clinical profiles
  • Haemodynamic monitoring
  • Improved quality of life
  • Reduced heart failure hospitalisations


  1. Hot Papers in Risk Factors and Comorbidities in Hypertension

M Camafort

  • Discussed 4 papers
  • Sacubitril/Valsartan may have advantages over valsartan in reversing ventricular remodeling
  • Ticagrelor Aspirin showed a greater effect in patients without hypertension than those with stroke


  1. RIGHT: Prolongation of anticoagulant after primary PCI

Post-procedural Anticoagulation After PCI for ST-segment Elevation Myocardial Infarction (STEMI): A Multicentre, Randomised, Double-blind Trial

P Vranckx

  • Anticoagulation after PCI does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI)
  • Routine Prolonged post-procedural anticoagulation (PPA) after PCI is safe but does not improve ischaemic outcomes at 30 days
  • 3 anticoagulants could not prevent 30-day ischaemic events